The largest database of trusted experimental protocols

Ultravist 370 mct

Manufactured by Bayer
Sourced in Germany

Ultravist 370 MCT is a contrast medium used in medical imaging procedures. It is composed of a non-ionic, water-soluble, iodinated compound that enhances the visibility of internal structures during diagnostic imaging tests, such as computed tomography (CT) scans.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using ultravist 370 mct

1

Dual-Energy CT Imaging of the Abdomen

Check if the same lab product or an alternative is used in the 5 most similar protocols
All CT examinations of the abdomen were acquired on a dual-layer dual-energy 64-channel CT scanner (IQon, Philips Healthcare, Cleveland, OH, USA) according to our institutional protocol. Contrast material was injected via a 20 G catheter into an ante-cubital vein with a rate of 2,5 ml/s using a dual syringe injection system (Stellant, MEDRAD, Indianola, Pennsylvania), followed by a 50 ml saline chaser. Portal venous phase images were obtained 70 s following intravenous administration of contrast material (80 ml Ultravist 370 MCT, Bayer Vital GmbH, Leverkusen, Germany). The scan was performed craniocaudally with a pitch of 0.9, tube voltage of 120 kVp, a 64x0.625-mm detector configuration, a rotation time of 0.33 seconds and an average CTDIvol of 7.8 mGy. All data sets were reconstructed in axial view with slice thickness of 5 mm and a 512-image matrix with an iDose image reconstruction algorithm level 2.
+ Open protocol
+ Expand
2

Dual-layer Dual-energy 64-channel CT Abdomen Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
A dual-layer dual-energy 64-channel CT scanner (IQon, Philips Healthcare, Cleveland, OH, USA) was used for the acquisition of all CT examinations of the abdomen according to our institutional protocol. A 20-G catheter and a dual-syringe injection system (Stellant, MEDRAD, Indianola, Pennsylvania) were used to apply a contrast agent (bolus of 80 ml Ultravist 370 MCT, Bayer Vital GmbH, Leverkusen, Germany). The contrast agent was administered into an ante-cubital vein with a rate of 3 ml/s, followed by a 50-ml saline chaser, and the portal venous phase images were obtained 70 s after the injection. All patients were scanned craniocaudally with a pitch of 0.9, a tube voltage of 120 kVp, and a 64 × 0.625 mm detector configuration. The reconstruction of the data sets was made in axial view using a 512-image matrix and slice thickness of 5 mm.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!